13.02.2013 Views

Karen Bedard and Karl-Heinz Krause

Karen Bedard and Karl-Heinz Krause

Karen Bedard and Karl-Heinz Krause

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

paired memory (875, 876). More specifically, NOX enzymes,<br />

particularly NOX2, might be involved in long-term<br />

potentiation <strong>and</strong> learning (438, 469). Indeed, all elements<br />

of the phagocyte NADPH oxidase are found in hippocampal<br />

neurons (866), <strong>and</strong> an NADPH oxidase, presumably<br />

NOX2, is involved in NMDA receptor signaling (462). Most<br />

importantly, learning <strong>and</strong> memory are impaired in NOX2<strong>and</strong><br />

p47 phox -deficient mice (461), as well as in CGD patients<br />

(682). Note, however, that the degree of learning<br />

<strong>and</strong> memory impairment is mild, suggesting either that<br />

NOX2 plays only a modulatory role or that various NOX<br />

isoforms have a redundant function.<br />

An interesting aspect of NOX enzymes in the CNS is<br />

their role in intercellular signaling. For example, ROS<br />

produced in hippocampal neurons during long-term potentiation<br />

diffuse into neighboring oligodendrocytes<br />

where they stimulate kinases (40); the resulting enhanced<br />

phosphorylation of myelin basic protein is thought to<br />

enhance myelinization (39).<br />

5. NOX enzymes in pathologies of the CNS<br />

ROS generation by NOX enzymes has been implicated<br />

in a variety of diseases of the CNS.<br />

A) ISCHEMIC STROKE. Stroke size was markedly reduced<br />

in NOX2-deficient mice (927), while increased NOX2 expression<br />

in diabetic rats was associated with an aggravated<br />

ischemic brain injury (496). In a gerbil model of<br />

global cerebral ischemia-reperfusion injury, apocynin<br />

strongly diminishes damage to the hippocampus (936).<br />

B) ALZHEIMER’S DISEASE, PARKINSON’S DISEASE, AND HIV DE-<br />

MENTIA. There is also increasing evidence for a role of<br />

microglial NOX2 in inflammatory neurodegeneration, including<br />

Alzheimer’s disease <strong>and</strong> Parkinson’s disease (152,<br />

983). In the case of Alzheimer’s disease (Fig. 8A), several<br />

THE NOX FAMILY OF ROS-GENERATING NADPH OXIDASES 277<br />

Physiol Rev VOL 87 JANUARY 2007 www.prv.org<br />

FIG. 8. Role of NOX enzymes in central nervous<br />

system (CNS) pathologies. Microglia are phagocytes of<br />

the CNS that express high levels of the phagocyte<br />

NADPH oxidase NOX2. ROS generation by microglia has<br />

been associated with the death of neighboring cells in<br />

the CNS. A: in the case of Alzheimer’s disease, the release<br />

of the amyloid precursor protein (APP) fragments<br />

amyloid � 40 <strong>and</strong> 42 (A�40/42) activates neighboring<br />

microglia cells. Once activated, NOX2 within the microglial<br />

cells generates ROS leading to neuronal cell death.<br />

B: oligodendrocyte death is an early event in the progression<br />

of demyelinating diseases. In the case of periventricular<br />

leukomalacia, microglia activation, e.g., through<br />

maternal or fetal infection, may lead to oligodendrocyte<br />

death. More specifically, lipopolysaccharide (LPS) leads<br />

to activation of microglial inducible NO synthase <strong>and</strong><br />

microglial NOX2, which generate peroxynitrate through<br />

the reaction of nitric oxide with superoxide. Peroxynitrate<br />

is a highly reactive oxygen species that is able to<br />

kill oligodendrocytes. Similar mechanisms might be involved<br />

in other demyelinating diseases such as multiple<br />

sclerosis.<br />

studies show a role of microglia in amyloid precursor<br />

protein (APP)-dependent neurodegeneration (152, 689,<br />

810). APP fragments released from neurons activate<br />

NOX2 in neighboring microglia cells (718) through a Vavdependent<br />

mechanism (953). The consequent ROS generation<br />

by microglial NOX2 leads to death of neighboring<br />

neurons (718). Several studies suggest similar mechanisms<br />

in Parkinson’s disease (91, 283, 284); however, the<br />

microglia-activating lig<strong>and</strong>s are less well defined. A strong<br />

argument for a role of NOX2 in Parkinson’s disease also<br />

comes from experiments in NOX2-deficient mice, which<br />

are protected in a MPTP model of Parkinson’s disease<br />

(985). Dementia is a common problem in advanced HIV<br />

disease, <strong>and</strong> microglia activation is thought to be a key<br />

element in the development of the disease (128); activation<br />

of NOX2 by the HIV-1 Nef suggests an involvement of<br />

NOX2 (919).<br />

ROS have also been implicated in the progression of<br />

the demyelinating disease (Fig. 8B). ROS produced by<br />

microglial NOX2 are required for the phagocytosis of<br />

myelin, yet these ROS can also cause damage to the<br />

myelin sheath (903). Periventricular leukomalacia is a<br />

focal necrosis of white matter in the brain that underlies<br />

most cases of cerebral palsy. In periventricular leukomalacia,<br />

the combination of NOX2-derived superoxide <strong>and</strong><br />

inducible nitric oxide synthase-derived nitric oxide leads<br />

to the formation of peroxynitrate <strong>and</strong> thereby to the killing<br />

of oligodendrites (535). The data on the role of the<br />

phagocyte NADPH oxidase system in autoimmune encephalomyelitis<br />

yielded complex results: depending on<br />

the length of the antigen that was injected, p47 phox -deficient<br />

or p47 phox mutant mice developed either a less<br />

severe or a more severe disease (399, 904). Also, genetic<br />

intercross experiments in susceptible <strong>and</strong> resistant rats<br />

Downloaded from<br />

physrev.physiology.org<br />

on February 2, 2010

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!